CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
Single needle +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00548626
NCT00548626N/ACompleted
CompareCT.gov

EMUNE-07 Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

University of Chicago·interventional·Posted Oct 24, 2007·Updated Dec 21, 2015

In Brief

A clinical study evaluating Single needle and Multiple needle for Pancreatic Cancer. Completed, enrolled 47 participants across 1 site.

Detailed Summary

The aim of this study is to evaluate if the early change of needle during EUS-FNA for suspected pancreatic cancer allows an earlier preliminary cytological diagnosis of neoplasia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesUnited States
CollaboratorsCook Group Incorporated

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 24, 2007
Enrollment StartOct 1, 2007
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8.1 yearsPosted 18.7 years ago

Interventions

Single needleprocedure

Patients will be sampled for a total of 6 consecutive FNA passes with a single EUS-FNA needle (only replaced if the needle has a reduced performance). After completing the 6th pass the endoscopist will be informed by the onsite cytopathologist about the preliminary cytological diagnosis.

Multiple needleprocedure

Patients will be sampled for a total of 6 consecutive FNA passes, replacing the needle after every 2 passes. After completing the 6th pass the endoscopist will be informed by the onsite cytopathologist about the preliminary cytological diagnosis.